Idenix Pharmaceuticals Inc. (IDIX) was a big mover last session, as its shares rose over 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the downtrend of the company since March 18, as the stock is now down almost 26%.
In the last 30-day frame, the company did not witness any estimate revision while the Zacks Consensus Estimate moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
Idenix currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the medical sector include ANI Pharmaceuticals, Inc. (ANIP), Alkermes plc (ALKS) and Alexion Pharmaceuticals, Inc. (ALXN). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment